Omar Flores Salmón
0000-0003-1883-3572
3 papers found
Refreshing results…
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
SARS‐CoV‐2 infections in households in a peri‐urban community of Lima, Peru: A prospective cohort study
Desarrollo de las Vacunas contra el SARS-CoV-2 y las implicancias relacionadas a la aparición de las variantes del virus
Missing publications? Search for publications with a matching author name.